| SYK |
SYK: Tyrosine-protein kinase SYK |
CD19 |
IPI00645331 |
2.6 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.595 |
Evidence |
O
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
RIT1 |
RIT1, RIBB, RIT, ROC1: GTP-binding protein Rit1 |
2.59 |
Evidence |
O
|
| GADD45B |
GADD45B, MYD118: Growth arrest and DNA-damage-inducible protein GADD45 beta |
PPARD |
PPARD, NR1C2, PPARB: Peroxisome proliferator-activated receptor delta |
2.59 |
Evidence |
|
| MAP1B |
MAP1B: Microtubule-associated protein 1B |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
2.58 |
Evidence |
|
| KIAA0052 |
SKIV2L2, KIAA0052: Superkiller viralicidic activity 2-like 2 |
EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
2.56 |
Evidence |
|
| RFC1 |
IPI00375359 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
2.56 |
Evidence |
|
| SUV39H1 |
SUV39H1, SUV39H: Histone-lysine N-methyltransferase SUV39H1 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
2.56 |
Evidence |
O
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.55 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
PLAU |
Plasminogen activator, urokinase |
2.547 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
CDC42 |
IPI00016786 |
2.547 |
Evidence |
|
| SGK |
SGK, SGK1: Serine/threonine-protein kinase Sgk1 |
SLC9A3R2 |
SLC9A3R2: SLC9A3R2 protein (Fragment) |
2.547 |
Evidence |
|
| HCK |
IPI00029769 |
BCR |
IPI00655824 |
2.547 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SLC9A3R2 |
SLC9A3R2: SLC9A3R2 protein (Fragment) |
2.547 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
BCR |
IPI00655824 |
2.547 |
Evidence |
|
| PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
PTPN11 |
IPI00298347 |
2.547 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CASP8 |
IPI00305242 |
2.547 |
Evidence |
|
| GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
YWHAG |
YWHAG: 14-3-3 protein gamma |
2.547 |
Evidence |
O
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
SLC9A3R2 |
SLC9A3R2: SLC9A3R2 protein (Fragment) |
2.547 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
PLAU |
Plasminogen activator, urokinase |
2.547 |
Evidence |
|
| CDC42 |
IPI00016786 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
2.547 |
Evidence |
|
| QARS |
QARS: Glutaminyl-tRNA synthetase |
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
2.542 |
Evidence |
O
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.52 |
Evidence |
O
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.52 |
Evidence |
|
| HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
2.52 |
Evidence |
O
|
-